| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |